Journal
CURRENT TOPICS IN MEDICINAL CHEMISTRY
Volume 8, Issue 6, Pages 521-530Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156802608783955737
Keywords
glucocorticoid; glucocorticoid receptor; transactivation; transrepression; agonist; dissociation; antagonist; tissue selectivity
Categories
Ask authors/readers for more resources
Glucocorticoids have been used in modern clinical practice for over fifty years. Although they have demonstrated potent anti-inflammatory and immunosuppressive activities, their association with debilitating and life-threatening side effects has been a major drawback. Recent insights into glucocorticoid biology have lent support to the hypothesis that the glucocorticoid anti-inflammatory activities could be dissociated from their adverse side effects. Inspired by these biological findings, the search for dissociated glucocorticoid receptor agonists has intensified. Antagonists of the glucocorticoid receptor that offer therapeutic benefits for the treatment of diseases such as diabetes have also been pursued. These efforts have been partly focused on the development of tissue, especially liver, selective glucocorticoid receptor antagonists, which are thought to have improved safety profiles. This review offers a summary of the research and development activities in this field and covers journal and patent publications from 2003 to March 2006.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available